Data-Driven Multimodal Subtyping Reveals Differential Cognitive Risk and Treatment Effects in the All of Us Cohort
This study utilized a Bayesian multimodal subtyping framework on over 121,000 cognitively unimpaired adults to identify four distinct risk profiles, revealing that those with cardiometabolic-depressive multimorbidity face the highest risk of developing mild cognitive impairment and derive the greatest protective benefit from antihypertensive and specific antidiabetic treatments.